{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:25:59Z","timestamp":1762079159921},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>American cutaneous leishmaniasis is an important endemic zoonotic disease in the New World that comprises a spectrum of clinical manifestations. Diffuse cutaneous leishmaniasis (DCL) is a rare form of the disease characterized by antigen-specific immunodeficiency that often presents with multiple disfiguring non-ulcerated confluent nodules or plaques that involve large areas of the skin, resembling lepromatous leprosy. Relapse is invariable in advanced stages, despite aggressive chemotherapy, and a plethora of drugs has been tested with unchanging results. We report on a severe an exceptional case that resolved after treatment with amphotericin B, a drug considered only mildly effective, and discuss the therapeutic approach to this disease.<\/jats:p>","DOI":"10.1111\/j.1365-2230.2009.03737.x","type":"journal-article","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T15:10:38Z","timestamp":1257261038000},"page":"e116-e119","source":"Crossref","is-referenced-by-count":8,"title":["Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B"],"prefix":"10.1093","volume":"35","author":[{"given":"B.","family":"Morrison","sequence":"first","affiliation":[{"name":"New York University School of Medicine, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Mendoza","sequence":"additional","affiliation":[{"name":"Dermatology Health Service, Estado Lara, Venezuela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Delgado","sequence":"additional","affiliation":[{"name":"Dermatology Health Service, Estado Lara, Venezuela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Reyes Jaimes","sequence":"additional","affiliation":[{"name":"Department of Dermatopathology\/Biochemistry Laboratory"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Aranzazu","sequence":"additional","affiliation":[{"name":"Clinical Section, Institute of Biomedicine, Caracas, Venezuela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Paniz Mondolfi","sequence":"additional","affiliation":[{"name":"Department of Dermatopathology\/Biochemistry Laboratory"},{"name":"Venezuelan Institute of Social Insurance, Health Directorate, Caracas, Venezuela"},{"name":"Department of Pathology and Laboratory of Medicine, St. Luke\u2019s-Roosevelt-Beth Israel Medical Center, University Hospital of Columbia, University College of Physicians and Surgeons, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,6,1]]},"reference":[{"key":"2023013105390781900_b1","first-page":"665","volume-title":"Hunter\u2019s Tropical Medicine and Emerging Infectious Diseases","author":"Magill","year":"2001","edition":"8th edn"},{"key":"2023013105390781900_b2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travelers","volume":"53","author":"Blum","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2023013105390781900_b3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.1965.01600110025007","article-title":"Disseminated cutaneous leishmaniasis","volume":"91","author":"Convit","year":"1965","journal-title":"Arch Dermatol"},{"key":"2023013105390781900_b4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0074-02762004000300001","article-title":"Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil \u2013 a review","volume":"99","author":"Silveira","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2023013105390781900_b5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-443-06790-7.50009-0","volume-title":"Tropical Dermatology","author":"Machado-Pinto","year":"2006","edition":"1st edn"},{"key":"2023013105390781900_b6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0035-9203(93)90030-T","article-title":"The clinical and immunological spectrum of American cutaneous leishmaniasis","volume":"87","author":"Convit","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023013105390781900_b7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10156-004-0348-9","article-title":"Challenges and new discoveries in the treatment of leishmaniasis","volume":"10","author":"Singh","year":"2004","journal-title":"J Infect Chemother"},{"key":"2023013105390781900_b8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4269\/ajtmh.2006.75.1074","article-title":"Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment","volume":"75","author":"Calvopina","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"2023013105390781900_b9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/510494","article-title":"Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B","volume":"44","author":"Amato","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2023013105390781900_b10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jinf.2005.03.012","article-title":"Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B","volume":"51","author":"Paradisi","year":"2005","journal-title":"J Infect"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03737.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/35\/4\/e116\/48958241\/cede116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/35\/4\/e116\/48958241\/cede116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:07:41Z","timestamp":1676383661000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/35\/4\/e116\/6622334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,6,1]]},"published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03737.x","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,6,1]]},"published":{"date-parts":[[2010,6,1]]}}}